Zelai He
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 14
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 3
-
- Nanoparticle-Based Drug Delivery 8
- Co-authors
- Huijun Zhang (6 shared papers)Yufeng Wu (6 shared papers)Jingwen Huang (6 shared papers)Xiangyu Zhang (2 shared papers)Xiangyu Zhang (6 shared papers)Wenjie Sun (2 shared papers)Ying Sun (3 shared papers)Yuanyuan Xu (1 shared paper)
- Journals
- Journal of Biomedical Nanotechnology (3 papers)Frontiers in Oncology (3 papers)Oncotarget (3 papers)BMC Cancer (2 papers)Annals of Translational Medicine (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zelai He
40 papers receiving 594 citations
Peers
Comparison fields: 5 of 90
- Biomaterials 170
- Cancer Research 70
- Pulmonary and Respiratory Medicine 136
- Pharmaceutical Science 25
- Biomedical Engineering 146
Countries citing papers authored by Zelai He
This map shows the geographic impact of Zelai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelai He more than expected).
Fields of papers citing papers by Zelai He
This network shows the impact of papers produced by Zelai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelai He. The network helps show where Zelai He may publish in the future.
Co-authors
The 25 scholars most cited alongside Zelai He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 98 | |
| 2 | 2019 | 39 | |
| 3 | 2015 | 38 | |
| 4 | 2015 | 37 | |
| 5 | 2019 | 35 | |
| 6 | 2016 | 27 | |
| 7 | 2020 | 27 | |
| 8 | 2013 | 27 | |
| 9 | 2020 | 27 | |
| 10 | 2020 | 25 | |
| 11 | 2014 | 23 | |
| 12 | 2016 | 20 | |
| 13 | 2015 | 19 | |
| 14 | 2016 | 18 | |
| 15 | 2024 | 17 | |
| 16 | 2022 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2019 | 14 | |
| 19 | 2022 | 9 | |
| 20 | 2023 | 9 |
About Zelai He
Zelai He is a scholar working on Oncology, Biomaterials, Pulmonary and Respiratory Medicine, Molecular Biology and Biomedical Engineering, having authored 45 papers that have together received 601 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers), Lung Cancer Research Studies (4 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Peptidase Inhibition and Analysis (3 papers) and Cardiac tumors and thrombi (2 papers). The work is most often cited by research in Biomaterials (170 citations), Cancer Research (70 citations), Pulmonary and Respiratory Medicine (136 citations), Pharmaceutical Science (25 citations) and Biomedical Engineering (146 citations). Zelai He has collaborated with scholars based in China and United States. Frequent co-authors include Huijun Zhang, Yufeng Wu, Jingwen Huang, Xiangyu Zhang, Xiangyu Zhang, Wenjie Sun, Ying Sun, Yuanyuan Xu, Xi Zhang and Ying Li. Their work appears in journals such as Journal of Biomedical Nanotechnology, Frontiers in Oncology, Oncotarget, BMC Cancer and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.